No image available
/ 6 November 2006

Coming to a friendly chemist near you

The last scuffle over the Medicines and Related Substances Act saw the health department announce a ­complex four-tier dispensing fee for pharmacists. This was intended to satisfy the requirement of the Constitutional Court, which last year ordered that an "appropriate" fee be drawn up for the purpose.

No image available
/ 27 October 2004

Villains through clumsiness

In the soap opera of the new transparent medicine pricing system, the latest unforeseen twist is the Pharmacy Council’s list of extra items for which pharmacists can charge over and above a drug’s single exit price, plus dispensing fee. Pharmacists have made it clear they intend to maintain their earnings by any means possible, ensuring that they now appear as the baddies in the medicine-pricing saga.

No image available
/ 27 July 2004

Profit is the only prognosis

The health care industry is increasingly coming under the beady eye of the Competition Commission and Competition Tribunal. The Council for Medical Schemes recently referred a commercial venture involving doctors in the Netcare group to the commission, believing it might not be in medical scheme members’ best interests.

No image available
/ 17 February 2004

Are doctors resisting change?

In the dying days of apartheid, FW de Klerk called his health minister, Rina Venter, and proposed the abolition of apartheid in state hospitals. During her subsequent investigations, Venter made a startling discovery: no laws specifically segregated hospitals. Doctors and hospital administrators had voluntarily enforced apartheid.

No image available
/ 26 January 2004

Don’t pop the champagne yet

A question put to me by a radio talk-show host last week suggested that the government’s publication of regulations to keep down medicine prices was an election ploy intended to win over voters. It would be rather stupid of the government not to do this before the election. But the truth is it’s been a long time coming.

No image available
/ 11 November 2003

The real road to hell

Afrox Healthcare CEO Michael Flemming minced no words in telling shareholders how the company derived its growing profits in the year to end-September. Medical inflation, he told Moneyweb, was responsible: the company charged about 10% more than the year before, while 5% was organic growth. Pat Sidley explains why a free-for-all in medical-aid rates is the ‘primrose path of dalliance’.